Usefulness of rCBF analysis in diagnosing Parkinson's disease: Supplemental role with MIBG myocardial scintigraphy

Annals of Nuclear Medicine

Volumn 22, Issue 7, 2008, Pages 557-564

  Nagamachi, Shigeki ^a   Wakamatsu, Hideyuki ^a   Kiyohara, Shogo ^a   Fujita, Seigo ^a   Futami, Shigemi ^a   Tamura, Shozo ^a   Nakazato, Masamitsu ^a   Yamashita, Syuichi ^a   Arita, Hideo ^a   Nishii, Ryuichi ^b   Kawai, Keiichi ^c  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Shiga Medical Center for Adults   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

3D SRT; 3D SSP; 123I MIBG; 99mTc HMPAO; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMALE; HEART; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; OCCIPITAL LOBE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; AGED; CEREBROVASCULAR CIRCULATION; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; OCCIPITAL LOBE; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 50949120591     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-008-0156-x     Document Type: Article

References (44)

1. D.B. Calne B.J. Snow C. Lee 1992 Criteria for diagnosing Parkinson's disease Ann Neurol 32 S125 S127
2. H. Nagayama M. Hamamoto C. Nito S. Takagi T. Miyazaki Y. Katayama 2000 Initial symptoms of Parkinson's disease with elderly onset Gerontology 46 129 132
3. M. Gross R. Bannister R. Godwin-Austen 1972 Orthostatic hypotension in Parkinson's disease Lancet 1 174 176
4. D.M. Wieland L.E. Brown W.L. Rogers K.C. Worthington J.L. Wu N.H. Clinthorne 1981 Myocardial imaging with a radioiodinated norepinephrine storage analog J Nucl Med 22 22 31
5. M. Yoshita M. Hayashi S. Hirai 1998 Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease Nucl Med Commun 19 137 142
6. S. Orimo E. Ozawa S. Nakade T. Sugimoto H. Mizusawa 1999 (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease J Neurol Neurosurg Psychiatry 67 189 194
7. S. Braune M. Reinhardt R. Schnitzer A. Riedel C.H. Lucking 1999 Cardiac uptake of [123I] MIBG separates Parkinson's disease from multiple system atrophy Neurology 53 1020 1025
8. H. Takatsu H. Nishida H. Matsuo S. Watanabe K. Nagashima H. Wada 2000 Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG J Nucl Med 41 71 77
9. 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease Ann Nucl Med 18 453 461
10. D. Fagret J.E. Wolf M. Comet 1989 Myocardial uptake of meta-[123I]-iodobenzylguanidine [(123I)-MIBG] in patients with myocardial infarct Eur J Nucl Med 15 624 628
11. 201Tl uptake and cardiac autonomic function Ann Nucl Med 12 323 331
12. P. Merlet J.L. Dubois-Rande S. Adnot M.H. Bourguignon C. Benvenuti D. Loisance 1992 Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idopathic dilated cardiomyopathy J Cardiovasc Pharmacol 19 10 16
13. S. Wakasugi A. Wada Y. Hasegawa S. Nakano N. Shibata 1992 Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine J Nucl Med 33 208 214
14. J. Spiegel M.O. Mollers 2005 FP-CIT and MIBG scintigraphy in early Mov Disord 5 552 561
15. T.S. Benamer J. Patterson D.G. Grosset J. Booij K. de Bruin E. van Royen 2000 Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group Mov Disord 15 503 510
16. Y. Imon H. Matsuda M. Ogawa D. Kogure N. Sunohara 1999 SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease J Nucl Med 40 1583 1589
17. M. Derejko J. Slawek D. Wieczorek B. Brockhuis M. Dubaniewicz P. Lass 2006 Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment Nucl Med Commun 27 945 951
18. Y. Mito K. Yoshida I. Yabe K. Makino K. Tashiro S. Kikuchi 2006 Brain SPECT analysis by 3D-SSP and clinical features of Parkinson's disease Hokkaido Igaku Zasshi 81 15 23
19. T. Sakai S. Kuzuhara 2006 Correlation of the cognitive function and the duration of the illness with the regional cerebral blood flow in the patients with Parkinson's disease: objective evaluation using stereotactic extraction estimation analysis in 123I-IMP SPECT (in Japanese) No To Shinkei 58 29 37
20. N.I. Bohnen S. Minoshima B. Giordani K.A. Frey D.E. Kuhl 1999 Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia Neurology 52 541 546
21. N. Oishi F. Udaka M. Kameyama N. Sawamoto K. Hashikawa H. Fukuyama 2005 Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations Neurology 65 1708 1715
22. Y. Arahata M. Hirayama T. Ieda Y. Koike T. Kato M. Tadokoro 1999 Parieto-occiptal glucose hypometabolism in Parkinson's disease with autonomic failure J Neurol Sci 163 119 126
23. H. Matsui F. Udaka T. Miyoshi N. Hara A. Tamura M. Oda 2005 Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features Parkinsonism Relat Disord 11 227 232
24. K. Van Laere P. Santens T. Bosman J.D. Reuck L. Mortelmans R. Dierckx 2004 Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlations with clinical parameters J Nucl Med 45 933 942
25. Y. Abe T. Kachi T. Kato Y. Arahata T. Yamada Y. Washimi 2003 Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing J Neurol Neurosurg Psychiatry 74 419 422
26. M.M. Hoehn M.D. Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442
27. L.N. Williams P. Seignourel G.P. Crucian M.S. Okun R.L. Rodriguez F.M. Skidmore 2007 Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease Mov Disord 22 141 145
28. H.L. Katzen B.E. Levin W. Weiner 2006 Side and type of motor symptom influence cognition in Parkinson's disease Mov Disord 21 1947 1953
29. D.J. Burn E.N. Rowan L.M. Allan S. Molloy J.T. O'Brien I.G. McKeith 2006 Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Levy bodies J Neurol Neurosurg Psychiatry 77 585 589
30. H. Matsuda A. Yagishita S. Tsuji K. Hisada 1995 A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime Eur J Nucl Med 22 633 637
31. 99mTc-ECD SPET Eur J Nucl Med Mol Imaging 29 331 341
32. H. Matsui F. Udaka M. Oda T. Kubori K. Nishinaka M. Kameyama 2005 Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy Auton Neurosci 119 56 60
33. M. Yoshita 1998 Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 metaiodobenzylguanidine myocardial scintigraphy J Neurosci 155 60 67
34. 123I] MIBG separates Parkinson's disease from multiple system atrophy Neurology 53 1020 1025
35. L.I. Wolfson K.L. Leenders L.L. Brown T. Jones 1985 Alteration of cerebral blood flow and oxygen metabolism in Parkinson's disease Neurology 35 1399 1405
36. Y. Arahata T. Kato K. Ito 2004 PET and SPECT studies in Parkinson's disease with dementia Cogn Dement 3 45 49
37. K. Ito P.K. Morrish J.S. Rakshi T. Uema J. Ashburner D.L. Bailey 1999 Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease J Neurosurg 66 754 758
38. V.A. Holthoff-Detto J. Kessler K. Herholz H. Bonner U. Pietrzyk M. Wurker 1997 Functional effects of striatal dysfunction in Parkinson disease Arch Neurol 54 145 150
39. F. Tanaka D. Vines T. Tsuchida M. Freedman M. Ichise 2000 Normal patterns on 99mTc-ECD brain SPECT scans in adults J Nucl Med 41 1456 1464
40. H. Ito K. Inoue R. Goto S. Kinomura Y. Taki K. Okada 2006 Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry Ann Nucl Med 20 131 138
41. N. Hishikawa Y. Hashizume M. Yoshida G. Sobue 2003 Clinical and neuropathological correlates of Lewy body disease ACTA Neuropathol 105 341 350
42. R.L. Albin S. Minoshima C.J. D'Amato K.A. Frey D.E. Kuhl A.A.F. Sima 1996 Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease Neurology 47 462 466
43. G.K. Wenning Y. Ben Shlomo M. Magalhaes S.E. Daniel N.P. Quinn 1994 Clinical features and natural history of multiple system atrophy: an analysis of 100 cases Brain 117 835 845
44. Fukuda H. Brain morphology and function: recent development in neuroimaging. 1st ed. Tokyo: Shinko Igaku; 2005. p. 117-127.